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Abstract Since the dissociation between adenomyoma and
endometriosis in the 1920s and the laparoscopic progress in
the diagnosis and surgery of endometriosis, the literature has
been greatly focused on the disease endometriosis. The
study of adenomyosis, on the other hand, has been neglected
as the diagnosis remained based on hysterectomy specimens.
However, since the introduction of magnetic resonance and
sonographic imaging techniques in the 1980s, the myometrial
junctional zone has been identified as a third uterine zone and
interest in adenomyosis was renewed. This has also been
the start for the interest in the role of the myometrial
junctional zone dysfunction and adenomyosis in reproductive
and obstetrical disorders.
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Introduction
Endometriosis and adenomyosis are both defined by the
presence of ectopic endometrial-like tissue, respectively outside
the uterus and in the myometrium. Although both disorders
were described under the common name of “adenomyoma” by
early authors [1] and extensively studied by Cullen [2] as one
condition, today they are considered two different diseases. The
dissociation practiced in the 1920s by Frankl [3] and Sampson
[4] is largely a consequence of the limitations in diagnostic tools
that have existed up to the mid-1980s. Today, new insights in
the structural and functional characteristics of the endometrium
and myometrial junctional zone (the “endomyometrium”), in
women with adenomyosis and endometriosis, provide
increasing evidence that they are frequently associated
and both are characterized by an aberrant function of the
endomyometrium. Data indicating that they could well
represent two phenotypes of a similar endomyometrial
dysfunction syndrome rather than two different diseases
have been accumulated—thanks to current imaging techni-
ques, functional, and molecular investigations. In addition,
evidence has also been gathered that the endomyometrial
dysfunction has major repercussion on reproductive functions.
The present review first describes the history and clinical
background of the two anomalies; subsequently, it outlines
reproductive dysfunctions existing in both disorders and,
finally, tries to define clinical features of the syndrome.
Historical diagnostic bias
Glandular inclusions in a number of pelvic sites were identi-
fied during the second part of the nineteenth century; their
presence created a controversy that continued for decades. It
was Cullen [5] that, in 1896, unequivocally stated that these
pelvic inclusions were derived from the “mucous membrane
of the uterus”. Then, in 1920, he provided a detailed descrip-
tion of a number of ectopic sites where the inclusions could be
present, including the outer myometrium, the rectovaginal
septum, uterine ligaments, the muscular wall of bladder and
bowel, and other abdominal structures and coined the lesions
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adenomyomas [2, 6] (Fig. 1). In 1927, Sampson [4]
formulated the hypothesis that “peritoneal endometriosis” was
“due to the menstrual dissemination of endometrial tissue into
the peritoneal cavity”. From there on, uterine adenomyosis,
which could not be explained by regurgitation of menstrual
elements, was coined in 1925 by Frankl [3] adenomyosis; and
endometriosis, with its separate pathogenesis, became widely
regarded as a disease entity distinct from adenomyosis.
Although already in the 40s, Novak and de Lima [7]
linked again adenomyosis and endometriosis, stating “one
cannot resist the feeling that there is some common denomi-
nator between endometrial hyperplasia and adenomyosis, and
possibly also pelvic endometriosis”, it was only over the last
two decades that the search for the underlying link between
endometriosis and adenomyosis received a major booster. The
development that provided the first important lead was the
introduction of magnetic resonance (MR) imaging; using this
technique, the “myometrial junctional zone” (JZ) was identi-
fied as a functional uterine zone to formwith the endometrium
the endomyometrium unit [8]. Shortly after, numerous molec-
ular studies showed that the endometrium in endometriosis
and adenomyosis is characterized by impaired cellular
responses to ovarian sex steroids [9], as well as by a number
of other metabolic aberrations.
Notwithstanding, these important developments, a major
stumbling block remained since the histological diagnosis of
endometriosis is based on a simple biopsy obtained at the
time of laparoscopy or laparotomy, while the diagnosis of
adenomyosis traditionally required a hysterectomy specimen.
Indeed, to this day, almost all studies involving adenomyosis
have been carried out on uteri removed at surgery. This has
major scientific consequences. First, according to Scopus, the
number of publications in 2011 on endometriosis is 22,730
and on adenomyosis 2,368, a tenfold difference. Secondly,
endometriosis is frequently diagnosed in its early stage by the
presence of variable or scarred peritoneal endometriosis, while
adenomyosis is rarely diagnosed during the early reproductive
life, its identification being made only after the appearance, in
older women, of symptoms of abnormal menstrual bleeding
and/or dysmenorrhea, severe enough to necessitate hysterec-
tomy. Consequently, endometriosis risks to be overdiagnosed,
while adenomyosis is neglected or overlooked.
The endomyometrium link
Aberrant eutopic endometrium
Although histologically normal, a series of biochemical
evaluations of the endometrium in women with endometriosis
and adenomyosis has, already in the late 1990s, revealed
profound disturbances. The eutopic endometrium in women
with these conditions is characterized by a large range of
abnormalities including alterations in immune cell population
[10], aberrant expression of aromatase [11], dysregulation of
IL-6 production [12], impaired temporal expression of beta3-
integrin [13], and HOX genes [14] and reduced spontaneous
apoptosis [15]. During the last decade, many more molecules
and functions have been found to be altered in endometriosis
[16] and adenomyosis [17].
An additional problem in any attempt at comparatively
analyzing endometrial abnormalities is given by the diag-
nostic modality utilized for endometriosis. On one hand,
endometrial biopsies are easily obtained at the time of
laparoscopy for the diagnosis of endometriosis; on the other,
the contemporary presence of adenomyosis cannot be excluded
in the vast majority of these studies due to the absence of a
hysterectomy specimen or imaging scan. As a consequence,
most studies on the endometrium in endometriosis have failed
to exclude the presence of adenomyosis, whereas, as it will be
detailed below, several studies—although disagreeing on the
percentage—have shown that the two conditions coexist in a
Fig. 1 Diagram showing localizations of ectopic endometrial tissue
(indicated as adenomyomas): 1, uterine wall; 2, rectovaginal septum; 3,
fallopian tubes; 4, round ligament; 5, hilum of ovary; 6, utero-ovarian
ligament; 8, colon; 9, musculus rectus; 10, umbilicus. From Cullen [2]
with permission
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significant proportion of cases; therefore, a major bias persists
in the biochemical evaluation of the eutopic endometrium in
womenwith endometriosis when adenomyosis is not excluded.
Aberrant myometrial junctional zone
Since the junctional zone myometrium started to be inves-
tigated by MR imaging, every abnormality observed has been
described as indicative of the presence of endometrium in the
outer myometrium or adenomyosis sensu stricto. In fact, how-
ever, distinction should be made between junction zone abnor-
malities and adenomyosis. Tocci et al. [18] have now proposed
that the “endometrial–subendometrial myometrium unit (or
junctional zone myometrium) disruption disease” be consid-
ered as a new entity distinguished from adenomyosis. The
diagnosis of which is feasible and straightforward on imaging.
This condition is expressed mainly by a pathological thicken-
ing or abnormality of the subendometrial myometrium (myo-
metrial halo or junctional zone). Clearly, there is a need for
uniform terminology and classification [19] and until this is
agreed upon, confusion will persist.
Although it is generally accepted that adenomyosis develops
as a result of downward growth of the endometrium into the
myometrium, MR imaging studies suggest that smooth muscle
proliferation and hyperplasia in the junctional zonemay precede
the outgrowth of endometrial cells [20]. Leyendecker et al. [21]
speculated that disruption of the specific uterine micro-
environment in the basal endometrium may explain the struc-
tural and functional abnormalities of the junctional zone, such as
hyperperistalsis, dysperistalsis, and inordinate smooth muscle
proliferation associated with endometriosis and adenomyosis.
In a case–control-blinded comparison, Mehasseb et al. [22]
studied the morphometric features of the myometrium in uteri
from pre- and postmenopausal womenwith andwithout uterine
adenomyosis as the sole pathology. Uteri were also divided
according to the phase of the cycle and examined using immu-
nohistochemistry and image analysis. The authors found clear
differences between the inner myometrium and the outer myo-
metrium, but the transition is gradual, with no distinct “zona-
tion”. Adenomyosis is characterized by reduced cell density
and increased nuclear size and features of hyperplasia and
hypertrophy that are not confined to the inner myometrium.
In a previous study, the same authors [23] found that smooth
muscle cells from uteri with adenomyosis are ultrastructurally
different from smooth muscle cells of normal uteri. They
suggested a possible effect of these distinct features on myo-
metrial contractility, together with hypertrophy.
Asssociation between endometriosis and adenomyosis
Using MR imaging, Kennedy et al. [24] found a high
correlation between the presence of endometriosis and of
adenomyosis in first degree relatives, suggesting that both
are phenotypes of a single disorder rather that two distinct
disease entities. Pelvic endometriosis, especially in severe
stages, is strongly associated with JZ thickening [25–27]. In
2005, Kunz et al. [26] tested the hypothesis of a strong
association between endometriosis and adenomyosis with
adenomyosis playing a role in causing infertility in women
with endometriosis. Using magnetic resonance imaging,
they found that the posterior junctional zone (PJZ) was
significantly thicker in women with endometriosis than in
those without the disease. The MR imaging method as
described in their previous publication [28] allowed them
to identify alterations of the junctional zone that were inter-
preted as signs of focal and diffuse adenomyosis, respec-
tively, according to the guidelines provided by Reinhold et
al. [29]. A threshold value of more than 10 mm was chosen,
above which with additional signs up to 12 mm, diffuse
adenomyosis was assumed. There was a positive correlation
of the diameter of the PJZ with the stage of the disease and
the age of the patients. The prevalence of adenomyotic
lesions in all 160 women with endometriosis was 79%.
In women with endometriosis below an age of 36 years
and fertile partners, the prevalence of adenomyosis was
90% (p<0.01). Kunz et al. [26] concluded that with a
prevalence of up to 90%, uterine adenomyosis is significantly
associated with pelvic endometriosis and constitutes an
important factor of sterility in endometriosis presumably by
impairing uterine sperm transport.
With respect to the effect of uterine contractions as
creating thickening of the JZ, Kunz et al. [26] clarified that
these contractions only exceeded those of healthy women
during the late menstrual and early follicular phase, whereas
the study was not restricted to these phases of the menstrual
cycle. Moreover, these contractions were never confined to
the posterior wall myometrium or prevailed as compared to
the anterior wall contractions, hence always comprising the
anterior as well as the posterior uterine myometrium within
one contraction wave. But only the PJZ showed this highly
significant difference in relation to the incidence of adeno-
myosis. They concluded that a possible bias with uterine wall
contractions influencing the findings obtained from the 227
patients cannot be absolutely excluded, but appears to be
negligible.
Traditionally, the diagnosis of adenomyosis is obtained
from women in their fourth to fifth decade of life. However,
recent MR imaging data suggest that adenomyosis may
develop much sooner in life, particularly in women with
endometriosis. In order to test this hypothesis, Kunz et al. [30]
performed MR imaging of the uterus in 227 women with and
without endometriosis and related the results to the age of the
subjects (age groups, 17–24, 25–29, 30–34, and >34 years).
The study revealed that the process of development of adeno-
myosis, represented by an increased diameter of the dorsal
junctional zone of the uterus (the imaging feature indicative of
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the invasion of basal endometrium into the junctional
zone), had already commenced early in the third decade
of life and progressed steadily during the fourth decade
in women with endometriosis. Women without endometriosis
showed almost no signs of adenomyosis up to the age of
34 years. Surprisingly, in both groups of women, a parallel
marked increase in the incidence of adenomyosis could be
observed beyond the age of 34 years, thus representing a
common phenomenon in the age-related pathophysiological
continuum of adenomyosis.
Furthermore, in a prospective study of 70 patients
presenting with severe dysmenorrhea, Kissler et al. [31]
found that dysmenorrhea of long duration in patients
who have had endometriosis for over a threshold value
of 11 years is significantly related to adenomyosis.
Hence, evaluation of adenomyosis using MRI should become
a standard procedure in cases of severe dysmenorrhea associ-
ated with endometriosis and, if of long duration, this symptom
should always pose a suspicion of adenomyosis. Finally, in
2010, Mijatovic et al. [32], in a retrospective study of 74
infertile patients with surgically proven endometriosis
(90.4% of them with endometriosis rASRM stages III–IV),
found also the presence of adenomyosis in 27% of them,
predominantly located in the posterior wall of the uterus.
Recently Larsen et al. [33] correlated the degree of
adenomyotic infiltration with the degree of infiltration
and stage of endometriosis. MR imaging of the uterus
was performed in 153 women with suspected deeply
infiltrating endometriosis and planned surgery, and in a
reference group of 129 women without endometriosis,
verified during hysterectomy. Diagnosis of adenomyosis
at MR imaging was based on optimal criteria derived
from the hysterectomy control group, while the stage of
endometriosis (rAFS stage) was determined during sur-
gery. The authors found that in the group of women with
endometriosis, 34.6% had adenomyosis compared with
19.4% in the reference group (p<0.05). More women
with endometriosis (39.9%) had an irregular JZ compared to
22.5% in the reference group (p<0.01). Among women with
severe endometriosis (AFS stage IV), 42.8% had adeno-
myosis compared to 29.4% in the women with other stages of
endometriosis (AFS stages I + II + III) (p00.10). More
women with severe endometriosis (AFS stage IV) had
deeper wall invasion of adenomyosis (p>0.05), but the
presence of deep infiltrative rectovaginal endometriosis
and the size of infiltration were not correlated to adenomyosis
or to the depth of infiltration of adenomyosis. The authors
concluded that, based on a systematic evaluation of the
junctional zone by MR imaging, severe symptomatic
endometriosis is in one third of the cases associated with
uterine adenomyosis. For some reason, however, “deep
endometriosis” and “deep adenomyosis” correspond only
to a limited degree.
The potential role of endomyometrial dysfunction
in reproductive and obstetrical disorders
In the normal human pregnancy, the remodeling of the spiral
arteries involves both their myometrial and decidual seg-
ments. There is growing evidence that a pre-pregnancy
disorder of the myometrial junctional zone is at the basis
of defective deep placentation which, in turn, is associated
with major reproductive and obstetrical complications [34].
Comparative studies on placentation show that the human is
not unique among primates in showing deep trophoblast
invasion [35], although recent investigations indicate that
the baboon, with no appreciable trophoblast invasion of the
myometrium is not an appropriate model for the study of
either endometriosis [36] or preeclampsia [35]. On the other
hand, there are case reports showing that preeclampsia may
occur in chimpanzees and gorillas where trophoblast invasion
and spiral artery remodeling are basically similar to the human
[37, 38].
Today, the investigation of reproductive outcomes in
young women with junctional zone abnormalities and/or
adenomyosis has become possible—thanks to MR imaging
and ultrasonography; using these techniques, an improved
and clinically useful correlation with histology-based diagno-
sis for adenomyosis has been accomplished [39, 40]—thanks
also to the analysis of the myometrial junctional zone. The
importance of myometrial junctional zone research in repro-
ductive medicine is frequently underestimated: indeed, the
inner myometrium is the critical zone for the adequate trans-
formation of spiral arteries supplying maternal blood to inter-
villous spaces of the placenta and a defective transformation
of myometrial spiral arteries in the placental bed has been
associated with major obstetrical syndromes [41].
The disappearance of the distinct myometrial zonal anato-
my very early during pregnancy onMR imaging has also been
observed in a unique case report by Turnbull et al. [42]. This
may correspond to the early decidualization process of the
myometrial spiral arteries in the placental bed well before the
zone is colonized by intravascular and interstitial trophoblast
[43, 44].
Impaired follicular function
A recent MR imaging study by Kunz and Beil [45] suggests
that the uterine junctional zone may be of significance with
respect to the early process of human reproduction. In 113
infertile women, the diameter of the anterior and posterior
JZ myometrium was documented by MR imaging prior to
the use of in vitro fertilization (IVF)/intracytoplasmic sperm
injection (ICSI). Each group of women was also subdivided
according to the presence [metaphase I (MI)/germinal vesicle
(GV) >0%] or absence (MI/GV00%) of MI and GVoocytes.
The MRI measurements were related to these and further
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parameters like expansion of the cumulus oophorus, pronuclei
stages, embryo morphology, and pregnancy rates. The authors
found that in all women with MI/GV00%, the JZ myome-
trium was significantly enlarged (p<0.004) and the clinical
pregnancy rate was significantly lower (p<0.025) compared
to that of women with MI/GV >0%. The authors suggested
that the JZ, as documented by MR imaging, might interfere
with follicular function.
Implantation failure and miscarriage
In a prospective clinical-imaging study including 152
patients, Maubon et al. [46] have explored the influence of
the uterine junctional zone thickness (as measured on pelvic
MR imaging), on implantation rates during IVF. They mea-
sured average and maximal junctional zone thickness values
and implantation outcomes were correlated with these values
and with infertility subtypes (endometriosis, tubal, dysovula-
tion, male, and unexplained). A junctional zone thickness
increase was significantly correlated with implantation failure
at IVF: implantation failure rate was 95.8% for patients with
an average junctional zone greater than 7 mm and a
maximal junctional zone greater than 10 mm, versus 37.5%
in other patient groups (p<0.0001), independently from cause
of infertility or patients’ age. The authors concluded that a
pelvic MR scan showing a thickened uterine junctional zone
has a negative predictive factor for embryo implantation after
IVF.
Tremellen and Russell [47] reported that in four women
who had previously undergone multiple unsuccessful in
vitro fertilization attempts, inactivation of adenomyosis by
an ultra-long pituitary downregulation regime, promptly
resulted in successful pregnancy for all four women. In
women with endometriosis, Mijatovic et al. [32] found no
significant differences for any of the IVF/ICSI outcomes
between women with and without concomitant adenomyosis
after pretreatment with GnRH agonist for 3 to 26 months.
Clearly, further prospective controlled studies are required to
clarify the impact of adenomyosis on implantation following
IVF.
Martinez-Conejero et al. [48] evaluated the effect of
adenomyosis on endometrial gene expression and reproduc-
tive outcome in an oocyte donation program. The clinical and
molecular data indicate that implantation is not affected by
adenomyosis, but higher rates of miscarriage were associated
with this condition leading to lower term pregnancies.
Major obstetrical syndromes
On the basis of pre-pregnancy imaging, Juang et al. [49]
reported that adenomyosis is an important risk factor for
spontaneous preterm delivery. Other recent studies have
shown that endometriosis is associated with preterm delivery
and other major obstetrical syndromes, such as small for
gestation age in the absence of hypertension, preterm delivery,
and obstetrical abnormal bleeding [50–52]. In evaluating the
significance of these investigations, once again the question
arises whether adenomyosis may not be a critical confounding
factor in the endometriosis studies as long as adenomyosis or
junctional zone hyperplasia is not systematically excluded by
imaging scan. In addition, advanced maternal age is not only
an important confounding factor for the likelihood of preg-
nancy complications, but is also associated with structural
changes in JZ anatomy as demonstrated by Kunz et al. [30].
Indeed, observational studies suggest that perturbations in JZ
structure or functions prior to conception predispose towards
impaired deep trophoblast invasion that underpins a spectrum
of obstetrical complications, including preterm birth [53–55]
Conclusions
While the link between endometriosis and endometriosis
has been puzzling, the role of the myometrial junctional
zone appears in both conditions to be associated with several
pathologically and clinically recognizable features. Therefore,
the presence of either endometriosis or adenomyosis should
alert the physician to the possible presence of the other. Both
tend to have a range of possible etiologies that could create a
set of reproductive and obstetrical disorders. Although the
reason that they occur together has not yet been discovered,
they have several molecular aberrations of the endometrium
and myometrial junction zone in common. As a consequence,
these features can justify the introduction of the endomyome-
trium dysfunctional syndrome.
Finally, there are several practical implications for research
and clinical management. It is clear that, from now on, bio-
chemical and clinical studies of the eutopic endometrium in
women with endometriosis need to document the presence or
absence of myometrial junctional zone abnormalities and
uterine adenomyosis.
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